FDA Drug Recalls

1,055 recalls · Class II, newest first

Mar 13, 2014 Class II · Moderate risk

Metformin Hydrochloride Tablets USP 1000 mg

Defective container: Product distributed without inner seal on bottles.

Terminated Packaging defect Blu Pharmaceuticals Inc NDC 24658-0292-05 D-1302-2014

Mar 13, 2014 Class II · Moderate risk

Metformin Hydrochloride Tablets USP 500 mg

Defective container: Product distributed without inner seal on bottles.

Terminated Packaging defect Blu Pharmaceuticals Inc NDC 24658-290-05 D-1301-2014

Mar 11, 2014 Class II · Moderate risk

Perrigo

Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.

Terminated Particulate / foreign matter Paddock Laboratories, LLC NDC 0574-0129-01 D-1168-2014

Mar 10, 2014 Class II · Moderate risk

Lupron Depot

Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.

Terminated Packaging defect AbbVie Inc NDC 0074-3642-03 D-1291-2014

Mar 10, 2014 Class II · Moderate risk

Lupron Depot

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Terminated Packaging defect AbbVie Inc NDC 0074-3663-03 D-1290-2014

Mar 10, 2014 Class II · Moderate risk

Lupron Depot-Ped

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Terminated Packaging defect AbbVie Inc NDC 0074-3779-03 D-1289-2014

Mar 10, 2014 Class II · Moderate risk

Lupron Depot

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Terminated Packaging defect AbbVie Inc NDC 0074-3473-03 D-1288-2014

Mar 10, 2014 Class II · Moderate risk

Lupron Depot

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Terminated Packaging defect AbbVie Inc NDC 0074-3346-03 D-1287-2014

Mar 4, 2014 Class II · Moderate risk

Zoledronic Acid Injection 5 mg per 100 mL

Lack of Assurance of Sterility; leaking of premix bags

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-830-82 D-1615-2014

Mar 4, 2014 Class II · Moderate risk

VIVITROL (naltrexone for extended-release injectable suspension)

Customer complaints for failure to deliver the dose.

Terminated Other Alkermes, Inc. NDC 65757-300-01 D-1556-2014

Mar 4, 2014 Class II · Moderate risk

Duloxetine Delayed-Release Capsules

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

Terminated Failed specification Teva Pharmaceuticals USA NDC 0093-7544-56 D-1184-2014

Mar 4, 2014 Class II · Moderate risk